Measles cases in the U.S. are at a 35-year high. Here's the staggering cost of falling vaccination rates for Americans.

By Micah Niermann

The U.S. officially lost its measles elimination status on Tuesday as it grapples with multiple outbreaks of the virus

The Pan American Health Organization just announced that the U.S. has lost its measles elimination status.

Measles is endemic in the U.S. once again. A disease that is deadly, highly contagious and yet also entirely preventable has claimed the lives of 10 adults and children so far this year. All were unimmunized, with at least four of them too young to have received the vaccine.

Before the measles vaccine was introduced in the U.S. in 1963, measles caused 450 to 500 deaths annually, on average. For those infected, there were risks of complications that could result in lifelong disabilities.

I work in the nation's first public hospital dedicated to the care of children with disabilities, and during our 130-year history, infectious diseases like measles impaired generations both physically and intellectually.

Care teams knew firsthand how children suffered alongside their families through the devastating complications of now-preventable illnesses like measles, polio, mumps, rubella and tetanus, to name a few.

In my state of Minnesota, a measles outbreak in Todd County, population 26,000, is incredibly concerning: There have been 136 cases since September, accounting for most of the reported 160 cases statewide since the beginning of the year. One hospital reported at least one patient with the measles in its emergency room each week this fall.

Measles can be devastating neurologically. One in 1,000 people with measles develop encephalitis, which can cause seizures, impairments such as deafness, and intellectual disability. A more serious, rare complication called subacute sclerosing panencephalitis (SSPE) emerges seven to 10 years after the initial infection. In this form, the infection causes a progressive and nearly always fatal neurological deterioration. The risk for this complication is highest in unimmunized infants. Our last patient with SSPE was treated as recently as 2018.

The best treatment for measles is to prevent it with the vaccine. There are some people who cannot get the vaccine, including infants younger than 6 months of age, women who are pregnant, people with a severe allergy to the vaccine and those who are immunocompromised. If these children and adults also have disabilities, their risk for serious complications increases dramatically.

These exceptions, however, do not explain the dramatic decrease in immunization rates across the country. When communities have vaccination rates of at least 95%, they achieve herd immunity, meaning measles cannot gain a foothold in the population.

Worryingly, the rate of measles vaccination among U.S. kindergartners was 92.4% for the 2025-26 school year, below the threshold for herd immunity. Over 75% of states saw immunization rates drop below 95% during the last full school year, according to health-policy research firm KFF. In Idaho, the rate was 75.2%. In West Virginia, however, 98.9% of kindergartners were vaccinated.

At the same time that vaccination rates have fallen, there has been an increase in exemptions. About 2.5% of children received vaccine exemptions in the 2019-20 school year, compared with 4.2% in the 2025-26 school year. That's mostly due to nonmedical exemptions, since there was a slight decrease in medical exemptions. Before the pandemic, only eight states had exemption rates exceeding 5%, but now 24 states do. This means that achieving herd immunity is impossible.

And if preventing death and disability is not convincing enough, people should know that treating and cleaning up after a measles outbreak is also expensive. A landmark study in 2021 calculated the cost of the 2018-19 measles outbreak in Washington state's Clark County at $47,479 per measles case and $3.4 million overall. Most of the money - about $2.3 million - went toward tracking down contacts of those who had measles and requiring quarantines. Approximately $1 million was lost work time for parents.

More recently, a new tool released by Johns Hopkins Bloomberg School of Public Health tallies both the direct and indirect costs of measles outbreaks across the country, with the ability to narrow the costs to each state. The current outbreaks have 5,739 cases, putting the total cost for the U.S. at about $93 million. Over half of these dollars are wrapped into the public health response, mostly going toward the steep up-front expense of mobilizing outbreak containment and monitoring. These unforeseen costs can shock tight state budgets, in part by forcing public health officials to spend their time working on these unexpected outbreaks.

These figures are just for measles. One study found that the routine childhood vaccines administered to children born between 1994 and 2023 are estimated to have prevented 508 million illnesses and 1.13 million deaths, and also to have saved $540 billion in direct medical costs and $2.7 trillion due to prevention. In other words, the return on investment is a staggering $11 for every $1 dollar spent on childhood vaccines.

What then is fueling this expensive trend against the conservation of lives and dollars?

This issue has been simmering for decades in the debunked science surrounding autism, but it came to a boil after the pandemic with deliberate misinformation from influencers, special-interest groups and now government leaders who have attempted to weaken federal policies for immunizations, all of which sow confusion and foment a growing mistrust in health professionals.

The result is an increasing acceptance of individual preference over community well-being.

We know the cost of individual preference for immunizations both in lives and dollars. This does not preclude choice. The data frames our choice clearly. We have enjoyed living in a world free of diseases that our grandparents and their families before them feared. The aftermath of these diseases may be a remote anecdote for many, but for those of us who see its effects and whose organizations have been dedicated to helping patients and families adjust to their new reality, it is all too real and sadly avoidable.

Micah Niermann is chief medical officer of Gillette Children's in St. Paul, Minn., a specialty hospital for children with disabilities, rare diseases and complex conditions.

-Micah Niermann

This content was created by MarketWatch, which is operated by Dow Jones & Co. MarketWatch is published independently from Dow Jones Newswires and The Wall Street Journal.

 

(END) Dow Jones Newswires

11-17-26 1147ET

Copyright (c) 2026 Dow Jones & Company, Inc.

The articles, information, and content displayed on this webpage may include materials prepared and provided by third parties. Such third-party content is offered for informational purposes only and is not endorsed, reviewed, or verified by Morningstar.

Morningstar makes no representations or warranties regarding the accuracy, completeness, timeliness, or reliability of any third-party content displayed on this site. The views and opinions expressed in third-party content are those of the respective authors and do not necessarily reflect the views of Morningstar, its affiliates, or employees.

Morningstar is not responsible for any errors, omissions, or delays in this content, nor for any actions taken in reliance thereon. Users are advised to exercise their own judgment and seek independent financial advice before making any decisions based on such content. The third-party providers of this content are not affiliated with Morningstar, and their inclusion on this site does not imply any form of partnership, agency, or endorsement.

Popular

Sponsor Center